Volume 12 Supplement 1
17th International Conference on Human Retroviruses: HTLV and Related Viruses
Meeting abstracts
Edited by Raymond Cesaire, Agnès Lézin and Jean-Marie Péloponèse Jr
Publication of this supplement was funded by EU PO-FEDER of Martinique. The Supplement Editors declare that they have no competing interests.
17th International Conference on Human Retroviruses: HTLV and Related Viruses. Go to conference site.
Trois Ilets, Martinique18-21 June 2015
Page 2 of 3
-
Citation: Retrovirology 2015 12(Suppl 1):P11
-
HTLV-1 inserts an ectopic CTCF-binding site into the human genome
Citation: Retrovirology 2015 12(Suppl 1):P12 -
Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P13 -
Comparative analysis of gene expression patterns in the HTLV-1 infected T-cell clones
Citation: Retrovirology 2015 12(Suppl 1):P14 -
In vivo characterization of the BLV miRNA cluster
Citation: Retrovirology 2015 12(Suppl 1):P15 -
KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1
Citation: Retrovirology 2015 12(Suppl 1):P16 -
In vitro basal T-cell proliferation and HTLV-1 proviral load among HTLV-1 subjects co-infected with Hepatitis C and/or HIV-1
Citation: Retrovirology 2015 12(Suppl 1):P17 -
Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia
Citation: Retrovirology 2015 12(Suppl 1):P18 -
HTLV-1 infected CD4+T cells of HAM/TSP patients are susceptible to tunicamycin-induced endoplasmic reticulum stress
Citation: Retrovirology 2015 12(Suppl 1):P19 -
Analysis of the association between the sex and disease courses of 132 consequent patients with HTLV-1-associated myelopathy/Tropic spastic paraparesis (HAM/TSP)
Citation: Retrovirology 2015 12(Suppl 1):P20 -
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P21 -
Comparison of clinical, immunological and virological markers in patients with HTLV-1 / HIV-1 co-infection with those with mono-infection
Citation: Retrovirology 2015 12(Suppl 1):P22 -
Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
Citation: Retrovirology 2015 12(Suppl 1):P23 -
Tax as a therapeutic target in ATL
Citation: Retrovirology 2015 12(Suppl 1):P24 -
Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
Citation: Retrovirology 2015 12(Suppl 1):P25 -
Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
Citation: Retrovirology 2015 12(Suppl 1):P26 -
HAM/TSP patient treated with porcine cortex monosialoganglioside: clinical outcome and follow up
Citation: Retrovirology 2015 12(Suppl 1):P27 -
Early hematopoietic stem cell transplantation improve treatment outcome of aggressive ATL.
Citation: Retrovirology 2015 12(Suppl 1):P28 -
Neurolymphomatosis in patient with Adult T-cell leukaemia/lymphoma (ATLL)
Citation: Retrovirology 2015 12(Suppl 1):P29 -
No evidence of association between Atherosclerosis, risk factors for cardiovascular disease and human T-cell lymphotropic virus type 1(HTLV-1) infection
Citation: Retrovirology 2015 12(Suppl 1):P30 -
Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
Citation: Retrovirology 2015 12(Suppl 1):P31 -
Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
Citation: Retrovirology 2015 12(Suppl 1):P32 -
Circulating exosomes as an enriched source for adult T-cell leukemia biomarkers
Citation: Retrovirology 2015 12(Suppl 1):P33 -
Human T-cell lymphotropic virus type 1 (HTLV-1) infection among couples of a cohort followed up in São Paulo, Brazil
Citation: Retrovirology 2015 12(Suppl 1):P34 -
Incidence of tropical spastic parapesis/ HTLV-1 associated myelopathy/ (TSP/HAM) in patients followed in a Reference center in Salvador, Brasil
Citation: Retrovirology 2015 12(Suppl 1):P35 -
HTLV Tax repress nonsense mediated mRNA decay by inhibiting the ATPase activity of UPF1
Citation: Retrovirology 2015 12(Suppl 1):P36 -
Tuberculosis (TB) incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil
Citation: Retrovirology 2015 12(Suppl 1):P37 -
Unpasteurized milk from the bulk tank used for calf-feeding might increase incidence of BLV in dairy farms
Citation: Retrovirology 2015 12(Suppl 1):P38 -
Assessment of functional capacity and flexibility of patients infected with HTLV-1
Citation: Retrovirology 2015 12(Suppl 1):P39 -
Patient satisfaction survey for HAM-net registrants
Citation: Retrovirology 2015 12(Suppl 1):P40 -
Epidemiological features of BLV infection in Japan from 2012 to 2013
Citation: Retrovirology 2015 12(Suppl 1):P41 -
Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
Citation: Retrovirology 2015 12(Suppl 1):P42 -
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Citation: Retrovirology 2015 12(Suppl 1):P43 -
HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients
Citation: Retrovirology 2015 12(Suppl 1):P44 -
T-cell receptor chain Vbeta subunit staining to quantify the malignant clone in adult T-cell leukemia
Citation: Retrovirology 2015 12(Suppl 1):P45 -
Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection
Citation: Retrovirology 2015 12(Suppl 1):P46 -
Generation of virus-like particle as a vaccine strategy against bovine leukemia virus
Citation: Retrovirology 2015 12(Suppl 1):P47 -
A novel bovine leukemia virus peptide vaccine targeting susceptible cattle-Production by 3-D modelling and nanotechnology
Citation: Retrovirology 2015 12(Suppl 1):P48 -
Epitope mapping of CD8+ T cells on bovine leukemia virus Gag, Env and Tax protein in cattle with different bovine MHC DRB3 alleles
Citation: Retrovirology 2015 12(Suppl 1):P49 -
A novel bovine leukemia virus peptide vaccine targeting susceptible cattle-Estimating vaccine effectiveness using susceptible cattle constructed by fertilized ovum transplantation
Citation: Retrovirology 2015 12(Suppl 1):P50 -
Improving the methodology for the detection of proviral integration sites in the host genome via high throughput sequencing
Citation: Retrovirology 2015 12(Suppl 1):P51 -
A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation
Citation: Retrovirology 2015 12(Suppl 1):P52 -
Suppression of HTLV-1 transcription by SIRT1 deacetylase
Citation: Retrovirology 2015 12(Suppl 1):P53 -
Akt activation by human T-cell leukemia virus tax oncoprotein
Citation: Retrovirology 2015 12(Suppl 1):P54 -
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections
Citation: Retrovirology 2015 12(Suppl 1):P55 -
Identification of TIGIT as an HBZ-induced gene by genome-wide analyses: its association with evasion of host defense
Citation: Retrovirology 2015 12(Suppl 1):P56 -
Tax as a therapeutic target in ATL
Citation: Retrovirology 2015 12(Suppl 1):P57 -
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
Citation: Retrovirology 2015 12(Suppl 1):P58 -
Reciprocal communication between mesenchymal stem cells and leukemic cells: role of junctional complexes and exosomes in adult T-cell leukemia progression
Citation: Retrovirology 2015 12(Suppl 1):P59 -
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Citation: Retrovirology 2015 12(Suppl 1):P60
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.3 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.004 - SNIP (Source Normalized Impact per Paper)
0.892 - SJR (SCImago Journal Rank)2023 Speed
8 days submission to first editorial decision for all manuscripts (Median)
83 days submission to accept (Median)2023 Usage
932,795 downloads
667 Altmetric mentions